JADPRO Live 2017 Educational Activities

These educational activities are based on presentations from JADPRO Live at APSHO 2017. Access the full-length video presentation, the slide deck, transcript, and the entire lecture as a podcast. Click on any of the video presentations below to get started!

All  |  AML  |  AML  |  BRCA  |  Immunotherapy  |  Immunotherapy  |  Immunotherapy  |  Immunotherapy  |  PARP  |  CML  |  MDS  |  MPN  |  Colon Cancer  |  Colorectal Cancer  |  Lynch Syndrome  |  mCRC  |  MSI-H  |  Rectal Cancer  |  CAR T-Cell Therapy  |  irAEs  |  irAEs  |  Side Effect Management  |  ALK Positive NSCLC  |  EGFR Resistance  |  Lymphomas and Leukemias  |  Bladder Cancer  |  Urothelial Carcinoma  |  GIST  |  Leiomyosarcoma  |  Soft Tissue Sarcomas  |  Surgery  |  Drug Development  |  MRD  |  Multiple Myeloma  |  Oral Therapies  |  Risk Stratification  |  Adjuvant Treatment  |  Breast Cancer  |  Diarrhea  |  HER2 Positive Breast Cancer

An Address From Dr. Richard Pazdur: How the Changing Landscape of Oncology Drug Development and Approval Will Affect Advanced Practice

Get an inside perspective on how the FDA updates its drug approval processes to reflect the changing oncology treatment environment and to incorporate the voice of the patient. With increasing numbers of oncology drug approvals and the ever-important area of molecularly targeted therapy, it is critical that advanced practitioners embrace and support this change.

Posted: January 22, 2018 / Expires: January 22, 2019

This certified activity has expired but you may watch the video without claiming credit.

Watch Video Without Claiming Credit


Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.